A CLINICAL EVALUATION OF TETRAETHYLTHIURAMDISULPHIDE (ANTABUSE) IN THE TREATMENT OF PROBLEM DRINKERS
Abstract
The Antabuse treatment of problem drinkers appears to be of definite value in the medical management of certain patients by significantly reducing the amount of time devoted to excessive drinking over a long period. It is more likely to prove of value in those persons showing no evidence of psychotic trends and lesser degrees of neurotic disposition. There is little evidence to indicate that it will bring about a permanent cure so that Antabuse may be discontinued after 6 months of ingestion of the drug when given as outlined. It is of utmost importance to recognize that psychotic reactions may occur while the patient is under Antabuse medication and that serious cardiovascular accidents may occur should the patient consume alcoholic beverages during the course of treatment.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
